Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST

Sansure Biotech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6501,6421,4581,0076,4504,515
Revenue Growth
-1.19%12.58%44.78%-84.39%42.88%-5.22%
Gross Profit
1,1701,2211,178726.153,5383,232
Operating Income
46.56133.85127.26-21.082,1942,526
Net Income
111.66198.94275.6363.721,9372,243
Earnings Per Share
0.190.340.470.623.313.81
EPS Growth
-52.54%-27.66%-24.19%-81.27%-13.12%-19.56%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
China
1,533
Overseas
83.08
Total
1,616

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,6244,1254,7304,7825,6644,683
Total Debt
1,5061,127422.8538.3127.8614.9
Net Cash (Debt)
2,1182,9984,3074,7435,6364,668
Net Cash Growth
-27.01%-30.39%-9.20%-15.83%20.74%12.83%
Net Cash Per Share
3.635.127.358.099.637.93

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
239.4183.96274.4543.542,5591,877
Capital Expenditures
-350.79-369.77-421.1-391.35-558.83-372.86
Free Cash Flow
-111.39-185.81-146.66-347.812,0001,504
Free Cash Flow Growth
----32.97%-40.63%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.95%74.40%80.82%72.10%54.85%71.58%
Operating Margin
2.82%8.15%8.73%-2.09%34.01%55.94%
Pretax Margin
5.07%10.67%17.87%40.76%35.90%57.95%
Profit Margin
6.77%12.12%18.90%36.12%30.03%49.68%
FCF Margin
-6.75%-11.32%-10.06%-34.53%31.01%33.32%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.5260.5230.5250.4621.2980.760
Dividend Per Share Growth
-2.05%-0.38%13.59%-64.39%70.77%0%
Dividend Yield
3.56%2.77%2.32%2.36%5.89%1.91%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
77.1754.5847.1730.766.5810.52
Forward PE
33.8026.2235.7551.118.1912.20
P/FCF Ratio
----6.3715.69
PS Ratio
5.086.618.9211.111.985.23